Elekta has a unique opportunity to fight cancer and alleviate the suffering of people affected by cancer in all corners of the world. The incidence of cancer is rising globally and there is a pressing need for radiotherapy services. Everyone deserves high-quality care, but it is not always available. Elekta is committed to improving access to radiotherapy for all, not least in currently underserved markets. The world community has set an ambitious target, as part of Agenda 2030, of reducing mortality from non-communicable diseases, such as cancer, by one third by 2030. Increasing access to radiotherapy will be crucial in reaching this target. Equitable access to medical care is a fundamental human right, and one we are committed to stand up for.


Not only are we contributing to this through our direct business purpose and our innovative and high-quality solutions to improve access. Also through our efforts in increasing education and training (with special focus on low- and middle income countries, see e.g. BrachyAcademy) and through our agenda for raising global awareness with carefully selected international organizations (e.g. City Cancer Challenge and Union for International Cancer Control).

 

Applicable sustainable development goals

Targets:

3.4    Reduce mortality from non-communicable diseases and promote mental health
3.C  Increase health financing and support health workforce in developing countries
4.4  Increase the number of people with relevant skills for financial success
17.6 Enhance the global partnership for sustainable development
17.17 Encourage effective partnerships

Elekta's contribution

  • Providing access to high-quality and innovative radiotherapy solutions globally.
  • Offering training and education on radiotherapy to healthcare professionals, particularly in low- and middle-income countries.
  • Collaborating and partnering with clinics, researchers, governments, and the civil society to develop new products and raise awareness about radiotherapy.
  • The Board of Directors is investigating the advantages of establishing a foundation in order to further strengthen Elekta's program for access to radiotherapy.

Contact Investor Relations

Cecilia Ketels

Head of Investor Relations

cecilia.ketels@elekta.com

Kira Haapanen

Investor Relations Manager

kira.haapanen@elekta.com